Shuang focuses her practice on the representation of public and private pharmaceutical, biotechnology, and other life sciences companies with respect to a variety of intellectual property-based commercial transactions, including licenses and research and development collaborations.

Download full bio 


  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 


  • Harvard Law School
    JD, 2019

  • University of Pennsylvania
    MS, Pharmacology

  • University of Arizona
    BS, Biochemistry and Molecular & Cellular Biology
    summa cum laude, 2011

Admissions & Credentials

New York

Not admitted to practice in Massachusetts